> top > docs > PMC:7408073 > spans > 307-703 > annotations

PMC:7408073 / 307-703 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T4 82-85 Body_part denotes RAS http://purl.obolibrary.org/obo/UBERON_0018229

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
21 210-213 Gene denotes ACE Gene:59272
22 218-222 Gene denotes ACE2 Gene:59272
23 356-361 Gene denotes renin Gene:5972
27 134-140 Species denotes humans Tax:9606
28 287-295 Species denotes patients Tax:9606
30 329-334 Chemical denotes metal MESH:D008670
32 278-286 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T4 278-286 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1177 134-140 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T48692 150-151 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T4 82-85 Chemical denotes RAS http://purl.obolibrary.org/obo/CHEBI_63620
T5 86-104 Chemical denotes pathway inhibitors http://purl.obolibrary.org/obo/CHEBI_76932
T6 94-104 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T7 183-193 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T8 223-227 Chemical denotes zinc http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185
T10 336-340 Chemical denotes zinc http://purl.obolibrary.org/obo/CHEBI_27363|http://purl.obolibrary.org/obo/CHEBI_30185
T12 342-351 Chemical denotes chelators http://purl.obolibrary.org/obo/CHEBI_38161
T13 362-372 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T5 36-313 Sentence denotes Based purely on experimental studies in which RAS pathway inhibitors were administered in vivo to humans/rodents, a reasonable hypothesis of using inhibitors that block both ACE and ACE2 zinc metalloproteases and their downstream pathways in COVID-19 patients will be proposed.